Acid sphingomyelinase deficiency is a rare, progressive genetic disease associated with significant morbidity and mortality.
Tiana Tran, PharmD
Advertisement
Articles by Tiana Tran, PharmD
Daridorexant demonstrated significant reduction in daytime sleepiness among other measures.
Advertisement
Latest Updated Articles
FDA Approves Olipudase Alfa-rpcp for Acid Sphingomyelinase DeficiencyPublished: November 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health
2
Why Trump’s Second Term is Different for the MFN Drug Pricing Policy
3
Taking Care of Every Patient in Every Pharmacy
4
Q&A: How Complex US Drug Market Impedes MFN Pricing Policy
5
